ZYBERNO
Stock Report
Updated Sep 1, 2026

Azitra, Inc. (AZTR)

Healthcare • NYSE

$0.18

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
Azitra, Inc. (AZTR) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-205.4%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.11x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-674.7%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Azitra, Inc. (AZTR) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.18
Market Cap:$3.41M

Valuation Multiples (2)

P/B Ratio:0.46x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$2.55M

Price Action & Momentum (3)

Momentum Percentile:1 / 100
% of 52-Week High:16.2%
B. Profitability Assessment

Return Metrics (5)

ROA:-161.7%
Reinvestment Rate:1.2%
Fundamental Growth Rate (g):-8.3%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$1.62K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:4.86x
Quick Ratio:4.86x
Cash Ratio:4.40x

Leverage Analysis (3)

Debt To Equity Ttm:0.11x
Debt-to-Equity Ratio:0.11x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-1,034.40x
Times Interest Earned:-1,034.40

Capital Structure (4)

Working Capital:5,913,113.00
Cash And Cash Equivalents:6,727,810.00
Long Term Debt:$408.57K
Net Debt:-$5.96M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$12.35M

Bottom Line Performance (3)

-$12.27M
Income Before Tax:-$12.26M
Ebitda Ttm:-12,191,965.00

Operating Expenses (5)

Operating Expenses:12,348,167.00
R And D Expense:5,096,163.00
Sga Expense:7,252,004.00
Income Tax Expense:$8.32K
Interest Expense:10,602.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$8.92M
Current Assets:$7.44M
Ppe Net:536,422.00
Goodwill:0.00
Intangible Assets:$330.04K

Liability Structure (4)

Total Liabilities:1,581,707.00
Current Liabilities:1,530,709.00
Long Term Debt:$408.57K
Short Term Debt:$357.57K

Equity & Capital (3)

Equity:$7.33M
Retained Earnings:-$75.80M
Common Stock:750,000,000.00

Working Capital Items (3)

Accounts Receivable:909.00
Inventory:0.00
Accounts Payable:497,985.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:11,405.00
C. Cash Flow Analysis

Operating Activities (2)

-$10.63M-$11.25M

Investment Activities (1)

Investing Cash Flow:-$37.14K

Financing Activities (3)

Financing Cash Flow:$10.50M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:215,950.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:156,202.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-2.26
-$2.26
Earnings Per Share Ttm:-$0.64

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.58

Book Value & Capital (2)

Book Value Per Share:$0.38
Cash Per Share:0.35

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:1.2%
Fundamental Growth Rate (g):-8.3%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):1.7%
C. Company Profile & Context

Corporate Information (6)

Symbol:AZTR
Company Name:Azitra, Inc.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NYSE
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:19.30M
Shares Outstanding Basic:19.30M
Shares Outstanding Diluted:19.30M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 20:09:17 UTC
Data Timestamp:2026-08-22T09:18:30.915743
Scroll to Top